Skip to content
Vividose®

For partners

Manufacture it, license it, carry it, or fund the rest of the path.

Vividose® is for people who already know syringes, hospital supply, or medical-device development. The patent is issued. A finished, regulated product is still ahead.

Manufacturing

The plan is to partner with an established syringe manufacturer. Work to date has been prototyping: seal color, barrel markings, and early molds. Tooling, minimums, sterile packaging, and unit cost are the conversation we want to have. No production contract is being announced.

Licensing

Product materials invite licensing requests for the patented technology. Treble Innovations holds the exclusive license to develop, manufacture, and sell it. If you already make dosing devices and want the colored-seal system in a line, start here.

Distribution and hospitals

Channels the company has had in view: hospital systems, syringe distributors, and direct conversations with clinicians. If you supply hospitals or clinics, we want to talk about how a high-visibility plunger would sit in an evaluation, not about a stocked catalog.

Investment

Personal capital has already gone into prototypes, patent prosecution, and the trademark. Further work — patient-ready prototypes, color and marking tests, and the regulatory path — needs a partner. We are not publishing a round size or a valuation.

A straight account

  • The device is not FDA-cleared. A 510(k) pathway has been planned. Clearance is not finished.
  • A 2021 product sheet listed sample pricing. That sheet is historical. It is not a current price list.
  • We do not publish medication-error statistics or clinical results.
  • Manufacturing is a partnership we are seeking. It is not a contract we are announcing.

What a first note should include

  • Your organization and role.
  • Whether this is manufacturing, licensing, distribution, a hospital evaluation, or investment.
  • What you need next: the patent number, a conversation about samples, or the regulatory status in writing.